Tsung H Lin
Research Subjects
Research Interests
Tsung H Lin has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- David A Wunderlich
Regulated Bioanalysis and Biotherapeutics Clinical Research, Pfizer Worldwide R&D, Groton, CT, USA
1 shared publication - Jaime L. Masferrer
Precision Medicine, Pfizer BioTx Clinical R&D, 200 Cambridge Park Drive, Cambridge, MA 02140, USA
1 shared publication - John B Cheng
Regulated Bioanalysis and Biotherapeutics Clinical Research, Pfizer Worldwide R&D, Groton, CT, USA
1 shared publication - Ming Zhu
Precision Medicine, Pfizer BioTx Clinical R&D, 200 Cambridge Park Drive, Cambridge, MA 02140, USA
1 shared publication - Susan Pleasic-Williams
Regulated Bioanalysis and Biotherapeutics Clinical Research, Pfizer Worldwide R&D, Groton, CT, USA
1 shared publication
Latest Publications
- Open Access
- 14 March 2013
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 11 (1) , 65
pSTAT3: a target biomarker to study the pharmacology of the anti-IL-21R antibody ATR-107 in human whole blood
IL-21 has been shown to play an important role in autoimmune diseases. ATR-107 is an antibody which directly targets the IL-21 receptor (IL-21R). To aid the clinical development of ATR-107, there is a need for understanding the mechanism of action (MOA) of this antibody when assessing target engagement in human subjects.
- 14 March 2013
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 11 (1) , 65
Open AccesspSTAT3: a target biomarker to study the pharmacology of the anti-IL-21R antibody ATR-107 in human whole blood
IL-21 has been shown to play an important role in autoimmune diseases. ATR-107 is an antibody which directly targets the IL-21 receptor (IL-21R). To aid the clinical development of ATR-107, there is a need for understanding the mechanism of action (MOA) of this antibody when assessing target engagement in human subjects.